Genetically engineered probiotic bacteria lower blood sugar in animal trials

Scientists have engineered probiotic bacteria that successfully lower high blood sugar levels in animal trials, according to a study published in Nature. The genetically modified bacteria could point toward a new approach to treating diabetes. Further research will be needed before any human applications are considered.